lobbying_activities: 2968066

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2968066	ca9daedc-8490-4013-a04f-77f35f04edf6	Q1	VAN SCOYOC ASSOCIATES	39837	ARUP LABORATORIES, INC.	2023	first_quarter	MED	H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other purposes, Diagnostic Lab Testing Laboratory Testing related issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally Pandemic All Hazards Preparedness Act, generally Monitor CURES 2.0, Diagnostic Lab Testing issues	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2023-04-19T11:11:09-04:00